HomeAYTU • NASDAQ
add
Aytu Biopharma Inc
Previous close
$2.59
Day range
$2.06 - $2.46
Year range
$0.95 - $3.24
Market cap
13.14M USD
Avg Volume
2.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 18.45M | 2.55% |
Operating expense | 10.38M | -25.36% |
Net income | 3.99M | 238.34% |
Net profit margin | 21.65 | 234.89% |
Earnings per share | — | — |
EBITDA | 3.74M | 1,341.86% |
Effective tax rate | -3.20% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.17M | -8.03% |
Total assets | 124.20M | -3.62% |
Total liabilities | 89.30M | -8.95% |
Total equity | 34.90M | — |
Shares outstanding | 6.17M | — |
Price to book | 0.46 | — |
Return on assets | 5.03% | — |
Return on capital | 11.61% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 3.99M | 238.34% |
Cash from operations | -6.46M | -2,441.34% |
Cash from investing | -69.00K | -53.33% |
Cash from financing | 4.30M | 711.13% |
Net change in cash | -2.22M | -1,063.20% |
Free cash flow | -8.63M | -246.32% |
About
Founded
2002
Headquarters
Website
Employees
99
